Insta
Swarajya Staff
Jun 23, 2020, 12:00 PM | Updated 12:00 PM IST
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
The Union government has provided details on the Rs. 2000 crore on the allocations made under PM CARES Fund for supply of 50000 ‘Made-in-India’ ventilators to government run COVID hospitals in all States/UTs.
Out of the 50000 ventilators, 30000 ventilators are being manufactured by M/s Bharat Electronics Limited. The remaining 20000 ventilators are being manufactured by AgVa Healthcare (10000), AMTZ Basic (5650), AMTZ High End (4000) and Allied Medical (350).
Out of the 2923 ventilators that have been manufactured, 1340 ventilators have already been delivered to the States/UTs. The prominent recipients include Maharashtra (275), Delhi (275), Gujarat (175), Bihar (100), Karnataka (90), Rajasthan (75). By the end of June 2020, additional 14,000 ventilators will be delivered to all States/UTs.
Migrant Labour Welfare
Further a sum of Rs. 1000 crore has already been released to States/UTs for welfare of the migrant labourers.
The distribution of the fund is based on the formula of 50% weightage for the population as per 2011 census, 40% weightage for number of positive COVID-19 cases and 10 % for equal distribution among all the States/UTs. This assistance is to be used for arranging accommodation, food, medical treatment and transportation of the migrants.
The main recipients of the grant are Maharashtra (181 cr), Uttar Pradesh (103 cr), Tamil Nadu (83 cr), Gujarat (66 cr), Delhi (55 cr), West Bengal (53 cr), Bihar (51 cr), Madhya Pradesh (50 cr), Rajasthan (50 cr) and Karnataka (34 cr).
Prime Minister’s Office (PMO) had announced last month that the Trust has decided to allocate Rs 3,100 core for the fight against Covid-19. Out of the Rs 3100 crore for which allocation was made, a sum of approximately Rs 2,000 crore was earmarked for the purchase of ventilators, Rs 1,000 crores will be used for care of migrant labourers and Rs 100 crores will be given to support vaccine development.